Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2017
01219962017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
A randomized phase II/III trial was started in May 2015 comparing perioperative versus postoperative chemotherapy with modified… (More)
Is this relevant?
2014
2014
PURPOSE To evaluate the clinicopathological characteristics and the outcomes of adjuvant chemotherapy of patients with colorectal… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2013
2013
  • 2013
Metastatic colorectal cancer (mCRC) is the third leading cause of cancer-related deaths in the United States. More than 143,460… (More)
Is this relevant?
Review
2012
Review
2012
PURPOSE OF REVIEW Febrile neutropenia presents a clinical challenge in which timely and appropriate antibiotic exposure is… (More)
Is this relevant?
2006
2006
A retrospective case-matched study was conducted to compare the oral regimen CTD (cyclophosphamide - thalidomide - dexamethasone… (More)
Is this relevant?
2006
2006
As no standard chemotherapy regimen has been established for advanced gastric cancer, this study sought to evaluate the efficacy… (More)
  • table I
  • table II
  • figure 1
  • table III
  • figure 2
Is this relevant?
2004
2004
BACKGROUND To compare the efficacy of continuous infusional 5-fluorouracil (5-FU)-based chemotherapy against conventional bolus… (More)
Is this relevant?
2001
2001
BACKGROUND Dose limiting acute toxicity from chemoradiation for pancreatic cancer occurs in 15% -20% of patients treated with… (More)
  • table 1
  • figure I
  • table 2
Is this relevant?
1998
1998
A phase II study was conducted to evaluate the activity and toxicity of 96-hour infusional paclitaxel in patients with previously… (More)
Is this relevant?
1996
1996
Infusional 5-fluorouracil (F) with cisplatin (C) and epirubicin (E), so-called infusional ECF, is a highly active new schedule… (More)
  • table II
  • table I
  • figure 2
  • figure 1
  • table V
Is this relevant?